Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Nadia Ghannam, Saleh Alahmed, Raed Aldahash, Naji Aljohani, Afaf Alshammary, Ashraf Amir, Abdullah Kamal, Said Khader, Mohammed Salah, Hani Shalabi, Ahmed Abdallah & Ahmed Elboghdady. (2023) Addressing the Continuum of Dysglycaemia and Vascular Complications in Prediabetes and Type 2 Diabetes: Need for Early and Intensive Treatment. Diabetes, Metabolic Syndrome and Obesity 16, pages 105-115.
Read now
Read now
Ulrike Gottwald-Hostalek & Mike Gwilt. (2022) Vascular complications in prediabetes and type 2 diabetes: a continuous process arising from a common pathology. Current Medical Research and Opinion 38:11, pages 1841-1851.
Read now
Read now
Ian W. Campbell. (2022) Metformin: a 60-year odyssey with the journey still continuing – a personal commentary from Professor Ian Campbell. Current Medical Research and Opinion 38:1, pages 55-58.
Read now
Read now
Articles from other publishers (25)
Eirini Klinaki & Mikolaj Ogrodnik. (2024) In the land of not-unhappiness: On the state-of-the-art of targeting aging and age-related diseases by biomedical research. Mechanisms of Ageing and Development 219, pages 111929.
Crossref
Crossref
Yolander Valentine & Barbara S. Nikolajczyk. (2024) T cells in obesity‐associated inflammation: The devil is in the details. Immunological Reviews.
Crossref
Crossref
Naglaa Hamdy, Mohamed Abdel-Gabbar, Hader I. Sakr, Mohamed A. Abdelaziz, Mohamed Kandeil, Ayman M. Abdel Aziz & Osama M. Ahmed. (2024) Efficacy of metformin on different adipocytokines in type 2 diabetes mellitus patients. Egyptian Pharmaceutical Journal 23:2, pages 207-215.
Crossref
Crossref
Amy Elizabeth Morgan & Mark Tomás Mc Auley. (2024) Vascular dementia: From pathobiology to emerging perspectives. Ageing Research Reviews 96, pages 102278.
Crossref
Crossref
Brian Burroughs. (2024) Metformin: An Important Treatment Consideration for Persons with Prediabetes Taking Antipsychotics. ADCES in Practice 12:2, pages 40-41.
Crossref
Crossref
Susha Dinesh, Sameer Sharma & Rajan Chourasiya. (2024) Therapeutic Applications of Plant and Nutraceutical-Based Compounds
for the Management of Type 2 Diabetes Mellitus: A Narrative Review. Current Diabetes Reviews 20:2.
Crossref
Crossref
Brian E. Rittenhouse, Sultan Alolayan, Tewodros Eguale, Alissa R. Segal & Joanne Doucette. (2024) The cost-effectiveness of metformin in the US diabetes prevention program trial: Simple interpretations need not apply. Preventive Medicine 178, pages 107819.
Crossref
Crossref
Massimo Volpe, Armando Ferrera, Roberto Piccinocchi & Carmine Morisco. (2023) The Emerging Role of Prediabetes and Its Management: Focus on l-Arginine and a Survey in Clinical Practice. High Blood Pressure & Cardiovascular Prevention 30:6, pages 489-496.
Crossref
Crossref
S. V. Madhu, P. V. Rao, H. B. Chandalia, K. Jothydev & A. Gupta. (2023) A multicentric, randomized, controlled trial of yoga and fenugreek in prevention of type 2 diabetes mellitus: methodological details—the Indian Prevention of Diabetes Study (IPDS). International Journal of Diabetes in Developing Countries 43:6, pages 875-882.
Crossref
Crossref
Anupam Garrib, Sokoine Kivuyo, Katie Bates, Kaushik Ramaiya, Duolao Wang, Edna Majaliwa, Rehema Simbauranga, Godbless Charles, Erik van Widenfelt, Huanyan Luo, Uazman Alam, Moffat J. Nyirenda, Shabbar Jaffar & Sayoki Mfinanga. (2023) Metformin for the prevention of diabetes among people with HIV and either impaired fasting glucose or impaired glucose tolerance (prediabetes) in Tanzania: a Phase II randomised placebo-controlled trial. Diabetologia 66:10, pages 1882-1896.
Crossref
Crossref
Eleonora Bruno, Antonino Mulè, Letizia Galasso, Lucia Castelli, Ivan Baldassari, Andreina Oliverio, Elisabetta Venturelli, Franco Berrino, Angela Montaruli, Eliana Roveda & Patrizia Pasanisi. (2023) Sleep behavior and daily activity levels in people with metabolic syndrome: effect of 1 year of metformin treatment. Frontiers in Nutrition 10.
Crossref
Crossref
Julita Tokarek, Emilian Budny, Maciej Saar, Kamila Stańczak, Ewa Wojtanowska, Ewelina Młynarska, Jacek Rysz & Beata Franczyk. (2023) Molecular Processes Involved in the Shared Pathways between Cardiovascular Diseases and Diabetes. Biomedicines 11:10, pages 2611.
Crossref
Crossref
Komal Jabeen, Kanwal Rehman, Muhammad Sajid Hamid Akash, Ahmed Nadeem & Tahir Maqbool Mir. (2023) Neuroprotective and Cardiometabolic Role of Vitamin E: Alleviating Neuroinflammation and Metabolic Disturbance Induced by AlCl3 in Rat Models. Biomedicines 11:9, pages 2453.
Crossref
Crossref
Kabelo Mokgalaboni & Wendy Nokhwezi Phoswa. (2023) Corchorus olitorius extract exhibit anti-hyperglycemic and anti-inflammatory properties in rodent models of obesity and diabetes mellitus. Frontiers in Nutrition 10.
Crossref
Crossref
Natasha Prakash Malkani & Vanita R. Aroda. (2023) Utilizing type 2 diabetes medications outside glycemic parameters – where are we headed?. Current Opinion in Endocrinology, Diabetes & Obesity 30:1, pages 1-6.
Crossref
Crossref
Ariane C Youssefzadeh, Laurel S Aberle, Brian Gordon, Intira Sriprasert, David A Sacks, Bhuvan Martin, Paola Sequeira & Richard H Lee. (2023) Postpartum Glucose Tolerance Testing Among Patients With Gestational Diabetes During the Coronavirus Disease 2019 Pandemic. Cureus.
Crossref
Crossref
Ana Lascu, Loredana N. Ionică, Darius G. Buriman, Adrian P. Merce, Loredana Deaconu, Claudia Borza, Octavian M. Crețu, Adrian Sturza, Danina M. Muntean & Horea B. Feier. (2022) Metformin and empagliflozin modulate monoamine oxidase-related oxidative stress and improve vascular function in human mammary arteries. Molecular and Cellular Biochemistry.
Crossref
Crossref
O. V. Tsygankova, N. E. Evdokimova, V. V. Veretyuk, L. D. Latyntseva & A. S. Ametov. (2022) Insulin resistance and heart failure with preserved ejection fraction. Pathogenetic and therapeutic crossroads. Diabetes mellitus 25:6, pages 535-547.
Crossref
Crossref
Chaiwat Washirasaksiri, Weerachai Srivanichakorn, Nutsakol Borrisut, Tullaya Sitasuwan, Rungsima Tinmanee, Chayanis Kositamongkol, Pinyapat Ariyakunaphan, Chonticha Auesomwang, Naruemit Sayabovorn, Thanet Chaisathaphol & Pochamana Phisalprapa. (2022) Fasting plasma glucose and HbA1c levels predict the risk of type 2 diabetes and diabetic retinopathy in a Thai high-risk population with prediabetes. Frontiers in Pharmacology 13.
Crossref
Crossref
Kevin P Mc Namara, Hamzah Alzubaidi, Margaret Murray, Catarina Samorinha, James A Dunbar, Vincent L Versace & David Castle. (2022) Should antidiabetic medicines be considered to reduce cardiometabolic risk in patients with serious mental illness?. Medical Journal of Australia 217:S7.
Crossref
Crossref
Hataikarn Nimitphong, Sitta Jiriyasin, Pisekporn Kasemasawachanon & Somnuek Sungkanuparph. (2022) Metformin for Preventing Progression From Prediabetes to Diabetes Mellitus in People Living With Human Immunodeficiency Virus. Cureus.
Crossref
Crossref
Yajiang Yuan, Xiangyi Fan, Zhanpeng Guo, Zipeng Zhou & Weiran Gao. (2022) Metformin Protects against Spinal Cord Injury and Cell Pyroptosis via AMPK/NLRP3 Inflammasome Pathway. Analytical Cellular Pathology 2022, pages 1-11.
Crossref
Crossref
Clifford J. Bailey & Mike Gwilt. (2022) Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin. Frontiers in Pharmacology 13.
Crossref
Crossref
Rao Zhou, Cristin M. Bruns, Ian M. Bird, Joseph W. Kemnitz, Daniel A. Dumesic & David H. Abbott. (2022) Experimentally Induced Hyperinsulinemia Fails to Induce Polycystic Ovary Syndrome-like Traits in Female Rhesus Macaques. International Journal of Molecular Sciences 23:5, pages 2635.
Crossref
Crossref
Mikhail V. Khvostov, Elizaveta D. Gladkova, Sergey A. Borisov, Nataliya A. Zhukova, Mariya K. Marenina, Yuliya V. Meshkova, Olga A. Luzina, Tatijana G. Tolstikova & Nariman F. Salakhutdinov. (2021) Discovery of the First in Class 9-N-Berberine Derivative as Hypoglycemic Agent with Extra-Strong Action. Pharmaceutics 13:12, pages 2138.
Crossref
Crossref